Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 31;5(1):522.
doi: 10.1038/s42003-022-03465-y.

Functional and phylogenetic analysis of TetX variants to design a new classification system

Affiliations

Functional and phylogenetic analysis of TetX variants to design a new classification system

Qipeng Cheng et al. Commun Biol. .

Abstract

Recently, many TetX variants such as Tet(X3~14) were reported to confer resistance to tigecycline which is a last-resort antibiotic used to treat infections caused by multidrug-resistant bacteria. In this study, we identified essential residues including 329, 339, 340, 350, and 351 in TetX variants that mediated the evolution of the tigecycline-inactive Tet(X2) enzyme to the active forms of Tet(X3) and Tet(X4). Based on their amino acid sequences and functional features, we classified TetX variants into TetX-A class, TetX-B class and TetX-C class. We further found that TetX-A class variants originated from Bacteroidetes, with some variants further evolving to TetX-C class and acquired by Enterobacteriaceae. On the other hand, our data showed that some variants genes belonging to TetX-A class evolved directly to TetX-B class, which was further transmitted to Acinetobacter spp. This new classification system may facilitate better clinical management of patients infected by TetX-producing strains.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Alignment of the complete amino acid sequences encoded by Tet(X) variants genes using BioEdit.
Amino acid residues are depicted in different color, the same amino acid is shown as dots in the alignment. Commonly mutated sites in Tet(X3), Tet(X4), Tet(X5), Tet(X6), and Tet(X7) compared with original TetX protein are highlighted in red box.
Fig. 2
Fig. 2. Location of related residues in the Tet(X)-tigecycline complex structure.
a Mapping the test amino acid substitution sites in the FAD-binding domain (deep olive), substrate-binding domain (cyan), and C-terminal helix (red). Residues are depicted as pink stick. b FAD and substrate-binding sites and mutation residues are showed in the model of Tet(X2) mutant (V329M/A339T/D340N/V350I/K351E). Loop 5 and mutant residues are shown as deep blue. Substrate-binding sites are depicted as green stick.
Fig. 3
Fig. 3. Phylogenetic analysis of TetX like protein.
a TetX-related proteins are divided into three classes: TetX-A (green), TetX-B (yellow), and TetX-C (orange). Phylogeny is inferred by using the maximum-likelihood method and Flu +G + I model. A discrete Gamma distribution approach was used to depict the difference in evolutionary rate among the sites [4 categories (Gamma shape parameter = 0.609)]. This analysis involved 128 amino acid sequences. Different species hits the protein sequences organized in the phylum level. Bacteroidetes, Proteobacteria, Firmicutes, Spirochetes, Bacteroidetes plus Proteobacteria, and unclassified organisms are shown in blue, pink, light purple, and gray, respectively. Evolutionary analyses were conducted in online PlyML 3.0. The tree was visualized using iTOL (ITEREACTIVE TREE OF LIFE). b Phylogenetic analysis of the amino acid sequences of the reported TetX variants. The maximum-likelihood tree was inferred using MEGA X. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. c Reported TetX variants are distributed in TetX-A class, TetX-B class, and TetX-C class with specific substitutions.

References

    1. Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol. Biol. Rev. 2001;65:232–260. doi: 10.1128/MMBR.65.2.232-260.2001. - DOI - PMC - PubMed
    1. Chukwudi CU. rRNA binding sites and the molecular mechanism of action of the Tetracyclines. Antimicrob. Agents Chemother. 2016;60:4433–4441. doi: 10.1128/AAC.00594-16. - DOI - PMC - PubMed
    1. Nguyen F, et al. Tetracycline antibiotics and resistance mechanisms. Biol. Chem. 2014;395:559–575. doi: 10.1515/hsz-2013-0292. - DOI - PubMed
    1. Rose WE, Rybak MJ. Tigecycline: first of a new class of antimicrobial agents. Pharmacotherapy. 2006;26:1099–1110. doi: 10.1592/phco.26.8.1099. - DOI - PubMed
    1. Noskin GA. Tigecycline: a new glycylcycline for treatment of serious infections. Clin. Infect. Dis. 2005;41:S303–314. doi: 10.1086/431672. - DOI - PubMed

Publication types